HEADER OXIDOREDUCTASE 11-MAY-12 4F4Q TITLE CRYSTAL STRUCTURE OF M. SMEGMATIS DPRE1 IN COMPLEX WITH FAD AND TITLE 2 COVALENTLY BOUND BTZ043 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DPRE1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: DPRE1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM SMEGMATIS; SOURCE 3 ORGANISM_TAXID: 246196; SOURCE 4 STRAIN: ATCC 700084 / MC(2)155; SOURCE 5 GENE: MSMEG_6382; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FAD DOMAIN, OXIDASE, BTZ043 COVALENTLY BOUND TO CYS394, KEYWDS 2 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.NERES,F.POJER,E.MOLTENI,L.CHIARELLI,G.RICCARDI,A.MATTEVI,S.T.COLE, AUTHOR 2 C.BINDA REVDAT 5 13-SEP-23 4F4Q 1 REMARK LINK REVDAT 4 15-NOV-17 4F4Q 1 REMARK REVDAT 3 19-SEP-12 4F4Q 1 JRNL REVDAT 2 12-SEP-12 4F4Q 1 JRNL REVDAT 1 05-SEP-12 4F4Q 0 JRNL AUTH J.NERES,F.POJER,E.MOLTENI,L.R.CHIARELLI,N.DHAR, JRNL AUTH 2 S.BOY-ROTTGER,S.BURONI,E.FULLAM,G.DEGIACOMI,A.P.LUCARELLI, JRNL AUTH 3 R.J.READ,G.ZANONI,D.E.EDMONDSON,E.DE ROSSI,M.R.PASCA, JRNL AUTH 4 J.D.MCKINNEY,P.J.DYSON,G.RICCARDI,A.MATTEVI,S.T.COLE,C.BINDA JRNL TITL STRUCTURAL BASIS FOR BENZOTHIAZINONE-MEDIATED KILLING OF JRNL TITL 2 MYCOBACTERIUM TUBERCULOSIS. JRNL REF SCI TRANSL MED V. 4 RA121 2012 JRNL REFN ISSN 1946-6234 JRNL PMID 22956199 JRNL DOI 10.1126/SCITRANSLMED.3004395 REMARK 2 REMARK 2 RESOLUTION. 2.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 15505 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 817 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.62 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 866 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.46 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE SET COUNT : 42 REMARK 3 BIN FREE R VALUE : 0.3130 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3179 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 87 REMARK 3 SOLVENT ATOMS : 82 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.04000 REMARK 3 B22 (A**2) : -0.04000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.685 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.300 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.203 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.476 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.898 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3377 ; 0.006 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4605 ; 1.108 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 415 ; 5.075 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 146 ;32.234 ;22.603 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 519 ;17.381 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 29 ;16.220 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 501 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2572 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4F4Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1000072452. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : BARTELS MONOCHROMATOR WITH DUAL REMARK 200 CHANNEL CUT CRYSTALS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PILATUS 2M-F DETECTOR REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16323 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.619 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.33 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.450 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4AUT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 11% PEG 300, 90 MM MES PH 5.9, 5% REMARK 280 TETRABUTYLAMMONIUM BROMIDE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.96200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 101.42050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.15450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 101.42050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.96200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.15450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 ALA A 3 REMARK 465 VAL A 4 REMARK 465 PRO A 5 REMARK 465 SER A 6 REMARK 465 LEU A 7 REMARK 465 THR A 8 REMARK 465 MET A 9 REMARK 465 SER A 10 REMARK 465 THR A 11 REMARK 465 THR A 12 REMARK 465 GLU A 13 REMARK 465 PHE A 14 REMARK 465 ASP A 275 REMARK 465 ALA A 276 REMARK 465 PRO A 277 REMARK 465 GLN A 278 REMARK 465 LEU A 279 REMARK 465 LEU A 280 REMARK 465 THR A 281 REMARK 465 LEU A 282 REMARK 465 PRO A 283 REMARK 465 ASP A 284 REMARK 465 ILE A 285 REMARK 465 PHE A 286 REMARK 465 PRO A 287 REMARK 465 ASN A 288 REMARK 465 GLY A 289 REMARK 465 LEU A 290 REMARK 465 ALA A 291 REMARK 465 ASN A 292 REMARK 465 LYS A 293 REMARK 465 PHE A 294 REMARK 465 THR A 295 REMARK 465 PHE A 296 REMARK 465 MET A 297 REMARK 465 PRO A 298 REMARK 465 ILE A 299 REMARK 465 GLY A 300 REMARK 465 GLU A 301 REMARK 465 LEU A 302 REMARK 465 LEU A 324 REMARK 465 ASP A 325 REMARK 465 MET A 326 REMARK 465 PHE A 327 REMARK 465 GLY A 328 REMARK 465 GLU A 329 REMARK 465 TRP A 330 REMARK 465 ASN A 331 REMARK 465 ARG A 332 REMARK 465 ALA A 333 REMARK 465 TYR A 334 REMARK 465 GLY A 335 REMARK 465 SER A 336 REMARK 465 ALA A 337 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 127 58.08 -95.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0SK A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 502 DBREF 4F4Q A 1 468 UNP A0R607 A0R607_MYCS2 1 468 SEQRES 1 A 468 MET GLY ALA VAL PRO SER LEU THR MET SER THR THR GLU SEQRES 2 A 468 PHE PRO THR THR THR LYS ARG LEU MET GLY TRP GLY ARG SEQRES 3 A 468 THR ALA PRO THR VAL ALA SER VAL LEU SER THR SER ASP SEQRES 4 A 468 PRO GLU VAL ILE VAL ARG ALA VAL THR ARG ALA ALA GLU SEQRES 5 A 468 GLU GLY GLY ARG GLY VAL ILE ALA ARG GLY LEU GLY ARG SEQRES 6 A 468 SER TYR GLY ASP ASN ALA GLN ASN GLY GLY GLY LEU VAL SEQRES 7 A 468 ILE ASP MET PRO ALA LEU ASN ARG ILE HIS SER ILE ASP SEQRES 8 A 468 SER GLY THR ARG LEU VAL ASP VAL ASP ALA GLY VAL SER SEQRES 9 A 468 LEU ASP GLN LEU MET LYS ALA ALA LEU PRO HIS GLY LEU SEQRES 10 A 468 TRP VAL PRO VAL LEU PRO GLY THR ARG GLN VAL THR VAL SEQRES 11 A 468 GLY GLY ALA ILE GLY CYS ASP ILE HIS GLY LYS ASN HIS SEQRES 12 A 468 HIS SER ALA GLY SER PHE GLY ASN HIS VAL ARG SER MET SEQRES 13 A 468 GLU LEU LEU THR ALA ASN GLY GLU VAL ARG HIS LEU THR SEQRES 14 A 468 PRO ALA GLY PRO ASP SER ASP LEU PHE TRP ALA THR VAL SEQRES 15 A 468 GLY GLY ASN GLY LEU THR GLY ILE ILE LEU ARG ALA THR SEQRES 16 A 468 ILE GLU MET THR PRO THR GLU THR ALA TYR PHE ILE ALA SEQRES 17 A 468 ASP GLY ASP VAL THR GLY SER LEU ASP GLU THR ILE ALA SEQRES 18 A 468 PHE HIS SER ASP GLY SER GLU ALA ASN TYR THR TYR SER SEQRES 19 A 468 SER ALA TRP PHE ASP ALA ILE SER LYS PRO PRO LYS LEU SEQRES 20 A 468 GLY ARG ALA ALA ILE SER ARG GLY SER LEU ALA LYS LEU SEQRES 21 A 468 ASP GLN LEU PRO SER LYS LEU GLN LYS ASP PRO LEU LYS SEQRES 22 A 468 PHE ASP ALA PRO GLN LEU LEU THR LEU PRO ASP ILE PHE SEQRES 23 A 468 PRO ASN GLY LEU ALA ASN LYS PHE THR PHE MET PRO ILE SEQRES 24 A 468 GLY GLU LEU TRP TYR ARG LYS SER GLY THR TYR ARG ASN SEQRES 25 A 468 LYS VAL GLN ASN LEU THR GLN PHE TYR HIS PRO LEU ASP SEQRES 26 A 468 MET PHE GLY GLU TRP ASN ARG ALA TYR GLY SER ALA GLY SEQRES 27 A 468 PHE LEU GLN TYR GLN PHE VAL VAL PRO THR GLU ALA VAL SEQRES 28 A 468 GLU GLU PHE LYS SER ILE ILE VAL ASP ILE GLN ARG SER SEQRES 29 A 468 GLY HIS TYR SER PHE LEU ASN VAL PHE LYS LEU PHE GLY SEQRES 30 A 468 PRO GLY ASN GLN ALA PRO LEU SER PHE PRO ILE PRO GLY SEQRES 31 A 468 TRP ASN VAL CYS VAL ASP PHE PRO ILE LYS ALA GLY LEU SEQRES 32 A 468 HIS GLU PHE VAL THR GLU LEU ASP ARG ARG VAL LEU GLU SEQRES 33 A 468 PHE GLY GLY ARG LEU TYR THR ALA LYS ASP SER ARG THR SEQRES 34 A 468 THR ALA GLU THR PHE HIS ALA MET TYR PRO ARG ILE ASP SEQRES 35 A 468 GLU TRP ILE ARG ILE ARG ARG SER VAL ASP PRO ASP GLY SEQRES 36 A 468 VAL PHE ALA SER ASP MET ALA ARG ARG LEU GLN LEU LEU HET 0SK A 501 28 HET FAD A 502 53 HET GOL A 503 6 HETNAM 0SK 8-(HYDROXYAMINO)-2-[(2S)-2-METHYL-1,4-DIOXA-8- HETNAM 2 0SK AZASPIRO[4.5]DEC-8-YL]-6-(TRIFLUOROMETHYL)-4H-1,3- HETNAM 3 0SK BENZOTHIAZIN-4-ONE HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 0SK C17 H18 F3 N3 O4 S FORMUL 3 FAD C27 H33 N9 O15 P2 FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *82(H2 O) HELIX 1 1 ASP A 39 GLY A 54 1 16 HELIX 2 2 PRO A 82 LEU A 84 5 3 HELIX 3 3 SER A 104 LEU A 113 1 10 HELIX 4 4 THR A 129 CYS A 136 1 8 HELIX 5 5 ASN A 142 GLY A 147 1 6 HELIX 6 6 SER A 148 ASN A 151 5 4 HELIX 7 7 ASP A 174 VAL A 182 1 9 HELIX 8 8 SER A 215 SER A 224 1 10 HELIX 9 9 GLY A 226 TYR A 231 5 6 HELIX 10 10 LYS A 259 LEU A 263 5 5 HELIX 11 11 PRO A 264 LYS A 269 1 6 HELIX 12 12 ASN A 316 HIS A 322 1 7 HELIX 13 13 ALA A 350 GLY A 365 1 16 HELIX 14 14 GLY A 402 PHE A 417 1 16 HELIX 15 15 THR A 423 ASP A 426 5 4 HELIX 16 16 THR A 430 TYR A 438 1 9 HELIX 17 17 ARG A 440 ASP A 452 1 13 HELIX 18 18 SER A 459 LEU A 465 1 7 SHEET 1 A 4 THR A 17 LEU A 21 0 SHEET 2 A 4 THR A 30 SER A 36 -1 O ALA A 32 N LYS A 19 SHEET 3 A 4 LEU A 77 ASP A 80 1 O ASP A 80 N LEU A 35 SHEET 4 A 4 VAL A 58 ARG A 61 1 N ARG A 61 O ILE A 79 SHEET 1 B 5 ILE A 87 ASP A 91 0 SHEET 2 B 5 LEU A 96 ASP A 100 -1 O ASP A 98 N HIS A 88 SHEET 3 B 5 ILE A 190 GLU A 197 -1 O ALA A 194 N VAL A 99 SHEET 4 B 5 VAL A 153 LEU A 159 -1 N GLU A 157 O LEU A 192 SHEET 5 B 5 VAL A 165 LEU A 168 -1 O ARG A 166 N LEU A 158 SHEET 1 C 2 LEU A 117 TRP A 118 0 SHEET 2 C 2 THR A 199 PRO A 200 -1 O THR A 199 N TRP A 118 SHEET 1 D 8 TYR A 310 GLN A 315 0 SHEET 2 D 8 PHE A 206 VAL A 212 -1 N PHE A 206 O GLN A 315 SHEET 3 D 8 ALA A 250 LEU A 257 -1 O ARG A 254 N ASP A 209 SHEET 4 D 8 TYR A 233 PHE A 238 -1 N TYR A 233 O GLY A 255 SHEET 5 D 8 ASN A 371 PHE A 376 -1 O PHE A 373 N ALA A 236 SHEET 6 D 8 GLY A 390 PRO A 398 -1 O ASN A 392 N LYS A 374 SHEET 7 D 8 PHE A 339 PRO A 347 -1 N LEU A 340 O PHE A 397 SHEET 8 D 8 ARG A 420 LEU A 421 -1 O ARG A 420 N VAL A 345 LINK SG CYS A 394 NBE 0SK A 501 1555 1555 1.75 CISPEP 1 PRO A 244 PRO A 245 0 8.79 SITE 1 AC1 12 GLY A 124 HIS A 139 GLY A 140 LYS A 141 SITE 2 AC1 12 LEU A 370 VAL A 372 LYS A 374 ASN A 392 SITE 3 AC1 12 CYS A 394 LYS A 425 FAD A 502 HOH A 680 SITE 1 AC2 32 TRP A 24 ILE A 59 ALA A 60 GLY A 62 SITE 2 AC2 32 LEU A 63 GLY A 64 ARG A 65 SER A 66 SITE 3 AC2 32 TYR A 67 ASN A 70 ALA A 71 MET A 81 SITE 4 AC2 32 ALA A 101 PRO A 123 GLY A 124 VAL A 128 SITE 5 AC2 32 THR A 129 GLY A 131 GLY A 132 CYS A 136 SITE 6 AC2 32 ILE A 138 HIS A 139 ASN A 185 GLY A 186 SITE 7 AC2 32 GLY A 189 ILE A 191 TYR A 422 ALA A 424 SITE 8 AC2 32 0SK A 501 HOH A 601 HOH A 641 HOH A 680 CRYST1 39.924 64.309 202.841 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025048 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015550 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004930 0.00000